Tenders/Part No. 1 - Avelumabum
Awarded🇵🇱PolandSupplies

Part No. 1 - Avelumabum

Auto-translated from Polish
Original title: Część nr 1 - Avelumabum
Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
Published: Oct 2, 2026
Updated: Oct 4, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish
1. The subject of the order is the purchase and successive delivery of oncological drugs and various drugs - Avelumabum 20mg/ml, concentrate for infusion solution x vial 10ml. 2. The detailed description of the subject of the order and the Ordering Party's requirements are specified in the price-offer form - Annex No. 1, which is an integral part of the SWZ. 3. The scope of the order includes the delivery of the ordered items in the quantities specified in the price-offer form for a period of 12 months. 4. The Ordering Party does not allow the submission of equivalent offers. 5. Purchase and successive delivery of the ordered items for 12 months from the date of contract conclusion. 6. The Ordering Party allows for the possibility of changing the validity period of the contract concluded with the Contractor in case the entire subject of the contract is not fulfilled during its term. In such a case, the contract amendment requires signing an annex, with the Ordering Party unilaterally notifying the Contractor of the proposed contract extension before its expiry date.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 2, 2026. Last refreshed 45 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie has issued 135 procurement notices on BidsFactory, including 6 currently open and 50 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU), Poland e-Zamówienia, and SmartPZP. Most recent publication: November 16, 2026.

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie: buyer profile, tenders and awards

Frequently asked questions about this tender

Is this tender still open?

No — the contract has already been awarded to URTICA Spółka z ograniczoną odpowiedzialnością; Roche Polska Spółka z ograniczoną odpowiedzialnością; Amgen Spółka z ograniczoną odpowiedzialnością; Sanofi Spółka z ograniczoną odpowiedzialności; ASCLEPIOS Spółka Akcyjna. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

URTICA Spółka z ograniczoną odpowiedzialnością; Roche Polska Spółka z ograniczoną odpowiedzialnością; Amgen Spółka z ograniczoną odpowiedzialnością; Sanofi Spółka z ograniczoną odpowiedzialności; ASCLEPIOS Spółka Akcyjna was awarded the contract for €29,783,086. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
🇵🇱Poland